Corcept Therapeutics
CORT
#2213
Rank
A$12.50 B
Marketcap
A$116.53
Share price
-2.34%
Change (1 day)
5.54%
Change (1 year)

Corcept Therapeutics (CORT) - Total debt

Total debt on the balance sheet as of March 2026 : A$13.73 Million

According to Corcept Therapeutics 's latest financial reports the company's total debt is A$13.73 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Corcept Therapeutics - Total debt on balance sheet (from 2003 to 2026)

Total debt by year

Year Total debt Change
2025-12-31A$9.11 M-18.24%
2024-12-31A$11.15 M4931.3%
2023-12-31A$0.22 M-86.8%
2022-12-31A$1.67 M131.5%
2021-12-31A$0.72 M-78.13%
2020-12-31A$3.31 M-32.89%
2019-12-31A$4.94 M
2018-12-31N/A
2016-12-31A$20.34 M-0.97%
2015-12-31A$20.54 M78.39%
2014-12-31A$11.51 M78.85%
2013-12-31A$6.43 M152.49%
2012-12-31A$2.55 M
2010-12-31N/A-100%
2009-12-31A$0 M-70.55%
2008-12-31A$0.02 M-31.63%
2007-12-31A$0.03 M-37.74%
2006-12-31A$0.05 M-27.81%
2005-12-31A$0.07 M
2003-12-31A$0.7 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
A$78.37 B 570,482.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$66.99 B 487,582.89%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$90.84 B 661,205.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$61.81 B 449,936.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$70.01 B 509,571.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$66.17 B 481,668.19%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
A$0.47 B 3,334.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
A$0.43 B 3,083.51%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$2.05 B 14,838.26%๐Ÿ‡บ๐Ÿ‡ธ USA